Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Insiders Buy Shares at Synta Pharmaceuticals and Aircastle

By

Plus, purchases at Nexpoint Credit Strategies Fund and American Realty Capital Partners.

PrintPRINT
Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside purchases recently filed with the SEC.

Notable Purchases:
  • Bruce Kovner, a director at the biopharmaceutical company Sytna Pharmaceuticals (NASDAQ:SNTA), which developers small molecule drugs for the treatment of cancer and inflammatory diseases, bought 5,000,000 shares of company stock for $18,750,000.
  • The Dallas, Texas-based alternative management firm Highland Capital Management bought 113,799 shares of non-diversified, close-ended management investment company Nexpoint Credit Strategies Fund (NYSE:NHF) stock for $1,000,362.
  • The Japanese trading company Marubeni (OTCMKTS:MARUF) bought 25,600 shares of high-utility commercial jet aircraft company Aircastle (NYSE:AYR) stock for $485,499.
  • Nicholas Schorsch, Chairman and CEO of real estate investment trust American Realty Capital Properties (NASDAQ:ARCP), bought 30,000 shares of company stock for $397,290.
For more insider trades, see the charts below.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
DIR,BO
B
$18,750,000
2
FO,DIR,BO
JB*
$11,637,500
3
BO
B
$1,278,027
4
O
B
$1,000,362
5
BO
B
$807,500
6
DIR
B
$562,500
7
DIR,BO
B
$485,499
8
CB,CEO
B
$397,290
9
BO
JB*
$325,000
10
CEO,CB,BO
B
$258,328

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
BO
JS*
$745,836,224
2
BO
S
$67,200,000
3
DIR
S
$59,325,000
4
BO
S
$39,894,668
5
BO
S
$37,567,232
6
CEO,DIR,BO
AS
$34,501,872
7
DIR,BO
JS*
$20,242,242
8
COO,CB,CEO
S
$15,001,350
9
CEO,DIR
JS*
$14,139,449
10
BO
JS*
$12,969,373

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights:

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of "Profit From Legal Insider Trading."
No positions in stocks mentioned.
PrintPRINT

Busy? Subscribe to our free newsletter!

Submit
 

WHAT'S POPULAR IN THE VILLE